Corbus Pharmaceuticals (CRBP)
(Delayed Data from NSDQ)
$34.25 USD
+0.75 (2.24%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $34.39 +0.14 (0.41%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth B Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/14/24 |
---|---|
Current Quarter | -1.09 |
EPS Last Quarter | -1.81 |
Last EPS Surprise | 23.31% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -5.21 |
Next Year | -5.12 |
EPS (TTM) | -10.37 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.09 | -1.21 | -5.21 | -5.12 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | -0.96 | -0.98 | -4.03 | -4.67 |
Low Estimate | -1.22 | -1.43 | -6.38 | -5.57 |
Year ago EPS | -4.24 | -2.05 | -10.31 | -5.21 |
Year over Year Growth Est. | 74.29% | 40.98% | 49.47% | 1.63% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.09 | -1.21 | -5.21 | -5.12 |
7 Days Ago | -1.09 | -1.21 | -5.21 | -5.12 |
30 Days Ago | -1.09 | -1.21 | -5.21 | -5.12 |
60 Days Ago | -1.87 | -1.92 | -8.10 | -9.04 |
90 Days Ago | -1.52 | -1.57 | -6.59 | -7.36 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.09 | -1.21 | -5.21 | -5.12 |
Zacks Consensus Estimate | -1.09 | -1.21 | -5.21 | -5.12 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.81 | -2.27 | -2.05 | -4.24 | NA |
Estimate | -2.36 | -2.06 | -3.10 | -4.09 | NA |
Difference | 0.55 | -0.21 | 1.05 | -0.15 | 0.31 |
Surprise | 23.31% | -10.19% | 33.87% | -3.67% | 10.83% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more